Richard A. Hartz

869 total citations
28 papers, 464 citations indexed

About

Richard A. Hartz is a scholar working on Behavioral Neuroscience, Organic Chemistry and Pharmacology. According to data from OpenAlex, Richard A. Hartz has authored 28 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Behavioral Neuroscience, 9 papers in Organic Chemistry and 9 papers in Pharmacology. Recurrent topics in Richard A. Hartz's work include Stress Responses and Cortisol (10 papers), Alkaloids: synthesis and pharmacology (5 papers) and Hormonal Regulation and Hypertension (5 papers). Richard A. Hartz is often cited by papers focused on Stress Responses and Cortisol (10 papers), Alkaloids: synthesis and pharmacology (5 papers) and Hormonal Regulation and Hypertension (5 papers). Richard A. Hartz collaborates with scholars based in United States, India and Germany. Richard A. Hartz's co-authors include Amos B. Smith, Naoki Kanoh, Haruaki Ishiyama, Darin J. Gustin, William Roush, Jon D. Rainier, Paul J. Gilligan, Noriaki Minakawa, Young Shin Cho and Vijay T. Ahuja and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Richard A. Hartz

26 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard A. Hartz United States 14 318 122 59 55 48 28 464
Xinrong Tian United States 14 501 1.6× 188 1.5× 72 1.2× 174 3.2× 23 0.5× 30 686
Subharekha Raghavan United States 11 552 1.7× 420 3.4× 68 1.2× 38 0.7× 56 1.2× 18 678
S. Kodato Japan 14 282 0.9× 257 2.1× 82 1.4× 57 1.0× 42 0.9× 16 505
Evelyne Delfourne France 19 479 1.5× 287 2.4× 133 2.3× 34 0.6× 252 5.3× 38 770
Susumu Kamata Japan 12 324 1.0× 164 1.3× 49 0.8× 23 0.4× 29 0.6× 24 449
Wen‐Lian Wu United States 15 479 1.5× 243 2.0× 47 0.8× 32 0.6× 32 0.7× 38 747
Jun Nakano Japan 11 231 0.7× 145 1.2× 34 0.6× 57 1.0× 23 0.5× 28 330
Melean Visnick United States 11 273 0.9× 132 1.1× 27 0.5× 34 0.6× 28 0.6× 19 405
Alec D. Lebsack United States 8 268 0.8× 107 0.9× 36 0.6× 55 1.0× 33 0.7× 15 374
Masahiko Bando Japan 18 285 0.9× 324 2.7× 60 1.0× 62 1.1× 55 1.1× 51 753

Countries citing papers authored by Richard A. Hartz

Since Specialization
Citations

This map shows the geographic impact of Richard A. Hartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Hartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Hartz more than expected).

Fields of papers citing papers by Richard A. Hartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Hartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Hartz. The network helps show where Richard A. Hartz may publish in the future.

Co-authorship network of co-authors of Richard A. Hartz

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Hartz. A scholar is included among the top collaborators of Richard A. Hartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Hartz. Richard A. Hartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoon, David, Chunjian Liu, Wei Wang, et al.. (2024). Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione. Journal of Medicinal Chemistry. 67(16). 14184–14199. 3 indexed citations
2.
McAuliffe, Brian, Jie Chen, Yan Chen, et al.. (2024). Preclinical Profile of the HIV-1 Maturation Inhibitor VH3739937. Viruses. 16(10). 1508–1508.
3.
Hartz, Richard A., Li Xu, Sing‐Yuen Sit, et al.. (2022). Synthesis, Structure–Activity Relationships, and In Vivo Evaluation of Novel C-17 Amine Derivatives Based on GSK3640254 as HIV-1 Maturation Inhibitors with Broad Spectrum Activity. Journal of Medicinal Chemistry. 65(23). 15935–15966. 2 indexed citations
4.
Xu, Li, Richard A. Hartz, Brett R. Beno, et al.. (2021). Synthesis, Structure–Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 Inhibitors. Journal of Medicinal Chemistry. 64(10). 6634–6655. 18 indexed citations
5.
Hartz, Richard A., Vivekananda M. Vrudhula, Vijay T. Ahuja, et al.. (2017). Synthesis and evaluation of prodrugs of corticotropin-releasing factor-1 (CRF1) receptor antagonist BMS-665053 leading to improved oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 27(6). 1360–1363. 3 indexed citations
6.
Denhart, Derek J., Dmitry Zuev, Jonathan L. Ditta, et al.. (2013). Potential CRF1R PET imaging agents: 1-Fluoroalkylsubstituted 5-halo-3-(arylamino)pyrazin-2(1H)-ones. Bioorganic & Medicinal Chemistry Letters. 23(7). 2052–2055. 4 indexed citations
7.
Lodge, Nicholas J., Snježana Lelas, Yu-Wen Li, et al.. (2012). Pharmacological and behavioral characterization of the novel CRF1 antagonist BMS-763534. Neuropharmacology. 67. 284–293. 2 indexed citations
8.
Li, Jianqing, Daniel Smith, Subramaniam Krishnananthan, et al.. (2011). An Efficient, Direct Bis-ortho-chlorination of 4-(Difluoromethoxy)aniline and Its Application to the Synthesis of BMS-665053, a Potent and Selective Pyrazinone-Containing Corticotropin-Releasing Factor-1 Receptor Antagonist. Organic Process Research & Development. 16(1). 156–159. 8 indexed citations
9.
Hartz, Richard A., Vijay T. Ahuja, William D. Schmitz, et al.. (2010). Synthesis and structure–activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(6). 1890–1894. 16 indexed citations
10.
Qian‐Cutrone, Jingfang, Richard A. Hartz, Vijay T. Ahuja, et al.. (2010). Chiral separation of potent corticotropin-releasing factor-1 receptor antagonists by supercritical fluid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 54(3). 602–606. 4 indexed citations
11.
Leahy, David K., Jun Li, Justin B. Sausker, et al.. (2010). Development of an Efficient Synthesis of Two CRF Antagonists for the Treatment of Neurological Disorders. Organic Process Research & Development. 14(5). 1221–1228. 11 indexed citations
12.
Zhuo, Xiaoliang, Richard A. Hartz, Joanne J. Bronson, et al.. (2009). Comparative Biotransformation of Pyrazinone-Containing Corticotropin-Releasing Factor Receptor-1 Antagonists: Minimizing the Reactive Metabolite Formation. Drug Metabolism and Disposition. 38(1). 5–15. 16 indexed citations
13.
Hartz, Richard A., Argyrios G. Arvanitis, Ge Zhang, et al.. (2005). Synthesis and evaluation of 2-anilino-3-phenylsulfonyl-6-methylpyridines as corticotropin-releasing factor1 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 16(4). 934–937. 57 indexed citations
14.
15.
Hartz, Richard A., Kausik K. Nanda, Vijay T. Ahuja, et al.. (2004). Design, Synthesis, and Biological Evaluation of 1,2,3,7-Tetrahydro-6H-purin-6-one and 3,7-Dihydro-1H-purine-2,6-dione Derivatives as Corticotropin-Releasing Factor1 Receptor Antagonists. Journal of Medicinal Chemistry. 47(19). 4741–4754. 9 indexed citations
16.
Gilligan, Paul J., Richard A. Hartz, Stephanie C. Koch, et al.. (2003). Pyrazolo-[1,5-a]-1,3,5-triazine corticotropin-Releasing factor (CRF) receptor ligands. Bioorganic & Medicinal Chemistry. 11(18). 4093–4102. 21 indexed citations
17.
Hartz, Richard A., et al.. (2002). Synthesis and evaluation of imidazo[1,5-a]pyrazines as corticotropin releasing hormone receptor ligands. Bioorganic & Medicinal Chemistry Letters. 12(3). 291–294. 14 indexed citations
18.
Smith, Amos B., Naoki Kanoh, Haruaki Ishiyama, & Richard A. Hartz. (2000). Total Synthesis of (−)-Penitrem D. Journal of the American Chemical Society. 122(45). 11254–11255. 48 indexed citations
19.
Roush, William, Richard A. Hartz, & Darin J. Gustin. (1999). Total Synthesis of Olivomycin A J. Am. Chem. Soc. 1999, 121, 1990−1991. Journal of the American Chemical Society. 121(16). 4092–4092.
20.
Smith, Amos B., Richard A. Hartz, P. Grant Spoors, & Jon D. Rainier. (1997). Tremorgenic Indole Alkaloids. 10. An Improved Asymmetric Synthesis of a Tricyclic Common Intermediate. Israel Journal of Chemistry. 37(1). 69–80. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinrong Tian Breakdown of academic impact, for papers by Subharekha Raghavan Breakdown of academic impact, for papers by S. Kodato Breakdown of academic impact, for papers by Evelyne Delfourne Breakdown of academic impact, for papers by Susumu Kamata Breakdown of academic impact, for papers by Wen‐Lian Wu Breakdown of academic impact, for papers by Jun Nakano Breakdown of academic impact, for papers by Melean Visnick Breakdown of academic impact, for papers by Alec D. Lebsack Breakdown of academic impact, for papers by Masahiko Bando
Rankless by CCL
2026